Goldman Sachs
PMI

Goldman Sachs’s Picard Medical PMI Stock Holding History

Goldman Sachs’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,660
Closed -$22.2K – 7136
2025
Q4 		$22.2K Buy
+12,660
New +$59.6K ﹤0.01% 6338

Other funds holding PMI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's PMI Position: Q1 2026 in Review

Goldman Sachs sold out of Picard Medical (PMI) in Q1 2026, closing a stake of 12,660 shares — an estimated $22.2K sold.

Goldman Sachs first reported a position in PMI in Q4 2025 and held it in 1 quarter. The position peaked at $22.2K in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • Goldman Sachs reported no remaining Picard Medical position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 12,660 Picard Medical shares in Q1 2026, an estimated $22.2K.
  • Goldman Sachs first reported a position in Picard Medical in Q4 2025 and held it in 1 quarter.
  • Goldman Sachs's Picard Medical position peaked at $22.2K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.